Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Effective policy and management decision-making increasingly depends on scientific and technological literacy.
Faculty
In The Wall Street Journal, Steven Cohen discusses how AI and robotics could transform New York City’s waste system.
(WSJ)
Faculty
Benjamin Perlman shares how simultaneously teaching in Columbia’s M.S. in Enterprise Risk Management program and leading ERM at ORIX enhances his work in both roles.
All News
